ReviewLaquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis
Under a Creative Commons license
open access
Keywords
Multiple sclerosis
Experimental autoimmune encephalomyelitis
Laquinimod
Disease modifying therapy
Immunomodulation
Cited by (0)
Copyright © 2014 The Authors. Published by Elsevier Inc.